Verona Pharma plc
VRNA
Classifica tra le azioni
#2213
Verona Pharma plc is a biopharmaceutical company currently in its clinical... Verona Pharma plc is a biopharmaceutical company currently in its clinical development phase, focusing on the research, development, and eventual market launch of new therapies for respiratory illnesses where current treatments are inadequate. Its primary experimental medication is ensifentrine, an inhaled compound designed to simultaneously block both phosphodiesterase (PDE) 3 and PDE4 enzymes. This unique mechanism allows it to function both as a bronchodilator, helping to open the airways, and as an anti-inflammatory agent within a single drug. Ensifentrine is presently undergoing advanced (Phase 3) clinical trials to evaluate its effectiveness in treating chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. To provide versatile administration options, the company is developing ensifentrine in three distinct formulations: a nebulizer solution, a dry powder inhaler (DPI), and a pressurized metered-dose inhaler (pMDI). Verona Pharma plc was established in 2005 and conducts its operations from its headquarters in London, United Kingdom.
Prezzo delle azioni
$106.91
Ultima sincronizzazione: 2025-10-07
Capitalizzazione di mercato
$9.09B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Verona Pharma plc (VRNA)
Categoria
Healthcare
Storico del prezzo dell'azione per Verona Pharma plc (VRNA)
Prezzo di chiusura più alto: $106.85 il 2025-10-01
Prezzo di chiusura più basso: $13.50 il 2017-04-01
Prezzo di chiusura più basso: $13.50 il 2017-04-01
Storico del prezzo dell'azione di Verona Pharma plc dal 2017 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2025 | 154.19% |
| 2024 | 157.60% |
| 2023 | -2.67% |
| 2022 | 215.71% |
| 2021 | -30.29% |
| 2020 | 68.43% |
| 2019 | -55.34% |
| 2018 | -13.21% |
| 2017 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $136.67 | -4.47% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
